황련추출물-ceramide 복합물의 지방장벽 형성 조절을 통한 상피 염증 완화 효과

키워드

참고문헌 (53)

1. Kim YJ, "The effect of retinoic acid on expression of human beta defensin-2and LL-37 in keratinocyte", J Korean Invest Dermatol, 14, pp.29~35 (2007)
2. 권민수, "세라마이드가 피부장벽 기능에 미치는 효과", 아시안뷰티화장품학술지, 3(1), pp.131~138 (2005), 한국피부과학연구원
3. 윤영민, "병풀과 엽산을 함유한 복합미생물 발효 추출물 및 아세틸글루타민, 니코틴산 아데닌 디뉴클레오티드 인산 복합물의 피부 세포노화 억제, 콜라겐생성 촉진, 세포재생 및 세포이동 촉진, 항염, 각질세포분화 촉진, 멜라닌생성 억제 효능", 아시안뷰티화장품학술지, 11(4), pp.675~684 (2013), 한국피부과학연구원
4. Steinert PM, "The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope", J Biol Chem, 270(30), pp.17702~17711 (1995)
5. Steven AC, "Protein composition of cornified cell envelopes of epidermal keratinocytes", J Cell Sci, 107(2), pp.693~700 (1994)
6. Elias PM, "Structural and lipid biochemical correlates of the epidermal permeability barrier", Adv Lipid Res, 24, pp.1~26 (1991)
7. Steinert PM, "Characterization of a class of cationic proteins that specifically interact with intermediate filaments", Proc Natl Acad Sci USA, 78(7), pp.4097~4101 (1981)
8. Cornelissen C, "IL-31 regulates differentiation and filaggrin expression in human organotypic skin models", J Allergy Clin Immunol, 129(2), pp.426~433 (2012)
9. Irvine AD, "Breaking the(un)sound barrier : filaggrin is a major gene for atopic dermatitis", J Invest Dermatol, 126(6), pp.1200~1202 (2006)
10. Palmer CN, "Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis", Nat Genet, 38(4), pp.441~446 (2006)
11. O'Regan GM, "The role of filaggrin in the atopic diathesis", Clin Exp Allergy, 40, pp.965~972 (2010)
12. Barnes KC, "An update on the genetics of atopic dermatitis : scratching the surface in 2009", J Allergy Clin Immunol, 125(1), pp.16~29 (2010)
13. Kim BB, "7, 3’, 4’-Trihydroxyisoflavone ameliorates the development of Dermatophagoides farinae-induced atopic dermatitis in NC", Nga Mice, 2013, pp.2013, 636597~
14. Weidinger S, "Atopic dermatitis", Lancet(London, England), 387(10023), pp.1109~1122 (2016)
15. 김정희, "아토피피부염의 최신지견", Allergy Asthma & Respiratory Disease, 14(1), pp.12~23 (2004), 대한 소아알레르기 호흡기학회
16. Boguniewicz M, "Atopic dermatitis : the updated practice parameter and beyond", Allergy Asthma Proc, 35(6), pp.429~434 (2014)
17. Byung Eui Kim, "Epidermal Barrier in Atopic Dermatitis", Allergy, Asthma & Immunology Research, 4(1), pp.12~16 (2012), 대한천식알레르기학회
18. Hogan MB, "Skin barrier function and its importance at the start of the atopic march", J Allergy(Cairo), 2012, pp.901940~ (2012)
19. Boguniewicz M, "Current management of atopic dermatitis and interruption of the atopic march", J Allergy Clin Immunol, 112(6), pp.140~150 (2003)
20. 임광모, "알레르기성 질환에 대한 한의학적 접근", 동의생리병리학회지, 16(5), pp.1~839 (2002), 한의병리학회
21. Cha HY, "Hataedock treatment has preventive therapeutic effects for atopic dermatitis through skin barrier protection in Dermatophagoides farinae-induced NC", Nga mice, 2017, pp.206, 327~336
22. Muluye RA, "Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs : a current review", J Tradit Complement Med, 4(2), pp.93~98 (2014)
23. Tang J, "Berberine and Coptidis Rhizoma as novel antineoplastic agents : a review of traditional use and biomedical investigations", J Ethnopharmacol, 126(1), pp.5~17 (2009)
24. Chin LW, "Anti-herpes simplex virus effects of berberine from Coptidis Rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San", Arch Virol, 155(12), pp.1933~1941 (2010)
25. 유영은, "한약재 추출물의 피부 염증 유발 세균에 대한 항균활성", 생명과학회지, 20(7), pp.1143~1150 (2010), 한국생명과학회
26. Jabbarzadeh Kaboli P, "Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer", Eur J Pharmacol, 740, pp.584~595 (2014)
27. Ortiz LM, "Berberine, an epiphany against cancer", Molecules, 19(8), pp.12349~12367 (2014)
28. Yu M, "Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NFkappaB", Mol Med Rep, 9(1), pp.249~254 (2014)
29. 김희경, "황련이 화상조직에 미치는 항산화와 항염증 및 피부재생 효과", 대한한의학회지, 32(2), pp.1~13 (2011), 대한한의학회
30. Forslin, B., "A domain mosaic model of the skin barrier", Acta Derrn Venereol, 74(1), pp.1~6 (1994)
31. Mohsenzadeh M, "Evaluation of antibacterial activity of selected Iranian essential oils against Staphylococcus aureus and Escherichia coli in nutrient broth medium", Pak J Biol Sci, 10(20), pp.3693~3697 (2007)
32. Rasul A, "Formulation development of a cream containing fennel extract: in vivo evaluation for anti-aging effects", Pharmazie, 67(1), pp.54~58 (2012)
33. 유학인, "HaCaT 세포에서 회향 열매의 피부장벽기능과 hyaluronic acid 생성에 미치는 영향", 생명과학회지, 25(8), pp.880~888 (2015), 한국생명과학회
34. Van Smeden J, "Stratum Corneum lipids : their role for the skin barrier function in healthy subjects and atopic dermatitis patients", Curr Probl Dermatol, 49, pp.8~26 (2016)
35. Steinert PM, "The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope", J Biol Chem, 270(30), pp.17702~17711 (1995)
36. Kwon YB, "Effects of colostrum on keratinocyte differentiation and wound healing", Kor J Invest Dermatol, 14(2), pp.45~50 (2007)
37. Smith FJ, "Loss of function mutations in the geneencoding filaggrin cause ichthyosis vulgaris", Nat Genet, 38(3), pp.337~342 (2006)
38. O'Regan GM, "The role of filaggrin in the atopic diathesis", Clin Exp Allergy, 40, pp.965~972 (2010)
39. Elias PM, ""Outside-to-Inside"(and now back to"Outside")pathogenic mechanisms in atopic dermatitis", J Invest Dermatol, 128(5), pp.1067~1070 (2008)
40. Kim BE, "Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6", Clin Immunol, 126(3), pp.332~337 (2008)
41. Hatano Y, "Interleukin-4suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis", J Invest Dermatol, 124(4), pp.786~792 (2005)
42. Albanesi C, "IL-4 and IL-13 negatively regulate TNF-alpha-and IFN-gamma induced beta-defensin expression through STAT-6, suppressor of cytokine signaling(SOCS)-1, and SOCS-3", J Immunol, 179(2), pp.984~992 (2007)
43. Proksch E, "The skin : an indispensable barrier", Exp Dermatol, 17(12), pp.1063~1072 (2008)
44. Baroni A, "Structure and function of the epidermis related to barrier properties", Clin Dermatol, 30(3), pp.257~262 (2012)
45. Rippke F, "Stratum corneum pH in atopic dermatitis : impact on skin barrier function and colonization with Staphylococcus Aureus", Am J Clin Dermatol, 5(4), pp.217~223 (2004)
46. 최응호, "아토피피부염의 병인", 대한의사협회지, 57(3), pp.218~225 (2014), 대한의사협회[DOI]
47. Kim HJ, "The effect of skin surface on epidermal permeability barrier", J Skin Barrier Res, 10(1), pp.44~55 (2008)
48. Chen JQ, "Roles of kallikrein-related peptidase in epidermal barrier function and related skin diseases", Int J Dermatol Venereol, 2(3), pp.150~155 (2019)
49. Yamamoto M, "Kallikrein-related peptidase-7 regulates caspase-14maturation during keratinocyte terminal differentiation by generating an intermediate form", J Biol Chem, 287(39), pp.32825~32834 (2012)
50. 안상현, "두시 하태독법의 IL-4 활성 조절이 D. farinae 유도 아토피유사피부염 발병 조절에 미치는 효과", 대한한방소아과학회지, 31(1), pp.43~51 (2017), 대한한방소아과학회
51. Li S, "Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network", IET Syst Biol, 1(1), pp.51~60 (2007)
52. 차호열, "황련-감초 추출물을 이용한 하태독법이 NC", Nga 생쥐에서 유발된 아토피 유사 피부염에 미치는 항염증 효과, 2015, pp.36(4), 486~497[DOI]
53. Fu S, "Coptisine suppresses mast cell degranulation and ovalbumin-induced allergic rhinitis", Molecules, 23(11), pp.3039~ (2018)

관련 논문AI추천